Therapeutic Drug Monitoring (TDM) is to optimize biologic treatment for an individual patient.
AFIAS Adalimumab allows for reliable measurement of Adalimumab drug levels using just
a small amount of human serum, plasma, or whole blood, delivering results in 10 minutes.
This allows clinicians to confirm the drug levels of Adalimumab immediately before the next administration.
Reagents, Therapeutic Drug Monitoring
Adalimumab
Measuring Adalimumab drug concentrations in patients being treated with Adalimumab for chronic autoimmune and inflammatory conditions
Reviews
There are no reviews yet.